Modular click libraries enable on-demand, high-throughput synthesis. Integrated with screening, they accelerate first-in-class drug discovery. These libraries provide a unique synthetic paradigm for Direct-to-Biology (D2B) screening without purification.
Tailored to customer molecules, transitioning from fixed-core library screening to on-demand instant synthesis.
Utilizing SuFEx technology to transcend traditional action modes, navigating patent barriers for emerging targets.
Connecting AI molecular design.
Build core-centric pipeline matrices while slashing library costs and shortening synthesis from months to 2 days.
Fixed core + phenotypic screening, recreating the legendary discoveries of penicillin and artemisinin.
Submit core structure/target requirements; consult on exclusive library construction solutions.
Submit